FP7H2020HORIZON
Miltenyi Biotec GmbH
- Country
- DEGermany
- Defence projects
- 0
- Projects, all programmes
- 34
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 9,044,883
- Active
- 2008 to 2024
Projects
34 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| STELLARStem-cell based therapy for kidney repair | FP7 | 2012 | Participant | EUR 413,000 |
| STROMAStromal Cell- Immune Cell Interactions in Health and Disease | FP7 | 2012 | Participant | EUR 203,712 |
| ATTACKAdoptive engineered T cell Trials to Achieve Cancer Killing | FP7 | 2012 | Participant | EUR 405,500 |
| DIABATRecruitment and activation of brown adipocytes as preventive and curative therapy for type 2 diabetes | FP7 | 2011 | Participant | EUR 386,800 |
| EUROCSCTRAININGEUROCANCER STEMCELL TRAINING NETWORK | FP7 | 2011 | Participant | EUR 191,606 |
| DOPANEWDopaminergic Neurons for Cell Therapy in Parkinson's Disease | FP7 | 2011 | Participant | EUR 184,574 |
| THE ONE STUDYA Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation | FP7 | 2010 | Participant | EUR 360,000 |
| CELL-PIDAdvanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency | FP7 | 2010 | Participant | EUR 395,720 |
| NANOIINanoscopically-guided induction and expansion of regulatory hematopoietic cells to treat autoimmune and inflammatory processes | FP7 | 2009 | Participant | EUR 250,000 |
| ATTRACTAdvanced Teaching and TRaining for Adoptive Cell Therapy | FP7 | 2009 | Participant | EUR 179,709 |
| OPTISTEMOptimization of stem cell therapy for clinical trials of degenerative skin and muscle diseases | FP7 | 2009 | Participant | EUR 620,200 |
| AXREGENAxonal regeneration, plasticity & stem cells | FP7 | 2008 | Participant | EUR 185,782 |
| STAR-T REKSet up and comparison of multiple stem cell approaches for kidney repair | FP7 | 2008 | Participant | EUR 180,300 |
| ANGIOSCAFFAngiogenesis-inducing Bioactive and Bioresponsive Scaffolds in Tissue Enginering | FP7 | 2008 | Participant | EUR 203,889 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.